German ZEW Survey results Expected On Tuesday
TestThe German ZEW survey is due on Tuesday 16th January and is so far the most awaited news of the first two days of this week’s trading. There is a lot of optimism in play as recent stats also show
Deprecated: Function get_magic_quotes_gpc() is deprecated in /home2/sharonox/public_html/wp-includes/formatting.php on line 1828
Deprecated: Function get_magic_quotes_gpc() is deprecated in /home2/sharonox/public_html/wp-includes/formatting.php on line 3603
Parke Bancorp Inc. (Nasdaq:PKBK) raises dividend to 6c from 5c per share; Validus Holdings, Ltd. (NYSE:VR), Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT)
By Peter Morris
Parke Bancorp Inc. (Nasdaq:PKBK) raises dividend to 6c from 5c per share. Parke Bancorp announced that, beginning with the quarterly cash dividend to be paid in April 2015, the board approved an increase in the dividend rate from 5c per share to 6c per share. "Our board is strongly committed to enhancing shareholder value in our company. We are able to increase the dividend as a result of the continued strong performance of the company," remarked president and CEO Vito S. Pantilione. PKBK traded in the green and closed at $11.57 for the day. The stock saw a change of $0.25(2.21%) with a volume of 334 shares. PKBK has a market cap of $69.33M.
Validus Holdings, Ltd. (NYSE:VR) reports Q4 operating EPS $1.42, consensus $1.22. Reports book value per diluted common share stands at $39.66, reflecting quarterly growth of 3.3% inclusive of dividends. Reports Q4 gross premiums written $336.6M, compared to $237.3M for the three months ended December 31, 2013. Reports Q4 net premiums earned $558.7M, compared to $492.2M for the three months ended December 31, 2013. VR is part of the financial sector in Property & Casualty Insurance industry. The stock closed for the day at $39.90 with a change of $0.02 or 0.05%. VR traded in a range of $39.40 to $40.41 through the day. The stock’s 52 week range is $34.68 to $42.35.
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) gets breakthrough designation from FDA for steatohepatitis treatment. Intercept Pharmaceuticals announced that its investigational product obeticholic acid, or OCA, has received "breakthrough therapy designation" from the FDA for the treatment of patients with nonalcoholic steatohepatitis, or NASH, with liver fibrosis. This indication constitutes a population of patients with a serious and life-threatening condition reflected by a higher risk of progression to cirrhosis and liver failure.The closing for ICPT was $170.69 at the day’s end. It was a change of $1.13. ICPT saw a volume of 548,686 shares and market cap of $3.65B.
Validus Holdings, Ltd. (NYSE:VR) reports Q4 operating EPS $1.42, consensus $1.22. Reports book value per diluted common share stands at $39.66, reflecting quarterly growth of 3.3% inclusive of dividends. Reports Q4 gross premiums written $336.6M, compared to $237.3M for the three months ended December 31, 2013. Reports Q4 net premiums earned $558.7M, compared to $492.2M for the three months ended December 31, 2013. VR is part of the financial sector in Property & Casualty Insurance industry. The stock closed for the day at $39.90 with a change of $0.02 or 0.05%. VR traded in a range of $39.40 to $40.41 through the day. The stock’s 52 week range is $34.68 to $42.35.
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) gets breakthrough designation from FDA for steatohepatitis treatment. Intercept Pharmaceuticals announced that its investigational product obeticholic acid, or OCA, has received "breakthrough therapy designation" from the FDA for the treatment of patients with nonalcoholic steatohepatitis, or NASH, with liver fibrosis. This indication constitutes a population of patients with a serious and life-threatening condition reflected by a higher risk of progression to cirrhosis and liver failure.The closing for ICPT was $170.69 at the day’s end. It was a change of $1.13. ICPT saw a volume of 548,686 shares and market cap of $3.65B.
Deprecated: Function get_magic_quotes_gpc() is deprecated in /home2/sharonox/public_html/wp-includes/formatting.php on line 1828
Deprecated: Function get_magic_quotes_gpc() is deprecated in /home2/sharonox/public_html/wp-includes/formatting.php on line 3603
By Peter Morris
Latest from MarketsDaily
-
-
US CPI on the Rise while Core Inflation is Steady
Test Annualized consumer price inflation (CPI) continued to push higher in November as expected, though core inflation unexpectedly held steady, official data showed on Thursday. U.S. consumer prices moderated in November, but the underlying trend continued to point to firming
-
UK Employment Falls Slightly In October
Test The jobs market stagnated in the three months to October, according to the latest jobs report from the Office for National Statistics, suggesting employers are finally slowing their hiring in the wake of June’s Brexit vote. The number of
-
Eurozone Industrial Production Fails In October
Test Eurozone industrial output dipped in October for the second consecutive month against expectations of a slight rise as production of intermediate and non-durable consumer goods dropped in a sign of muted growth in the fourth quarter according to data
-
U.S Import Prices Fall In November
Test U.S. import prices recorded their biggest drop in nine months in November on declining petroleum costs, with renewed dollar strength threatening to keep imported inflation subdued. The Labor Department said on Tuesday import prices fell 0.3 percent last month
-
Asian Development Bank cuts India’s 2016 growth estimate
Test The Asian Development Bank (ADB) today cut its 2016 growth estimate for India to 7 per cent from the previous 7.4 per cent on account of demonetization, weak investment and agricultural slowdown. The ADB had, in March last year,
